Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
Titel:
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
Auteur:
Penel, N. Le Cesne, A. Bui, B.N. Perol, D. Brain, E.G. Ray-Coquard, I. Guillemet, C. Chevreau, C. Cupissol, D. Chabaud, S. Jimenez, M. Duffaud, F. Piperno-Neumann, S. Mignot, L. Blay, J.-Y.